🇺🇸 FDA

Intelligence · Patent portfolio

RIGEL PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for RIGEL PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
373
Expiring ≤24m
18

Quick answer

RIGEL PHARMACEUTICALS has 373 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 18 expire within 24 months — use filters for patent-cliff planning.

Page 4 of 8

  1. US 9255085

    Carboxamide compounds and methods for using the same

    Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9248132

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9248190

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9206161

    Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9181222

    Protein kinase C inhibitors and uses thereof

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9181220

    N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9173882

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9174964

    AMPK-activating piperidinyloxy-substituted 2,3-dihydro-1H-indene-1-amine compounds and pharmaceutical compositions including the same

    Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9169249

    Protein kinase C inhibitors and uses thereof

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9162989

    2,4-Pyrimidinediamine compounds and their uses

    Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9156820

    Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9149475

    Protein kinase C inhibitors and uses thereof

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9145433

    GDF-8 inhibitors

    Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9133133

    2,4-pyridinediamine compounds and their uses

    Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9096542

    Kinase inhibitors and their uses

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9095593

    Protein kinase C inhibitors and uses thereof

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9084795

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9079898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9067925

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9062068

    Protein kinase C inhibitors and uses thereof

    Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9062052

    Carboxamide compounds and methods for using the same

    Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9040543

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9040061

    Topical formulation for administering a compound

    Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9040550

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9040527

    Pyrimidinediamine kinase inhibitors

    Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9034881

    Treatment for vitiligo

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9018204

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8993585

    Cyclic amine substituted pyrimidinediamines as PKC inhibitors

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8987303

    AMPK-activating heterocyclic compounds and methods for using the same

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8980921

    AMPK-activating heterocyclic compounds and methods for using the same

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8962643

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8951504

    (trimethoxyphenylamino) pyrimidinyl formulations

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8933080

    Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8927564

    Synthesis of polycyclic alkaloids

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8912170

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8906922

    Substituted triazoles useful as AXl inhibitors

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8895578

    Carboxamide, sulfonamide and amine compounds and methods for using the same

    Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8853397

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8846908

    Tricyclic carbamate JAK inhibitors

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8846600

    Carboxamide compounds and methods for using the same

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8835430

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8822685

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8815848

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8809370

    AMPK-activating heterocyclic compounds and methods for using the same

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8809341

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8809347

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8809364

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8796254

    Methods for using carboxamide, sulfonamide and amine compounds

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does RIGEL PHARMACEUTICALS have?

373 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do RIGEL PHARMACEUTICALS patents expire?

18 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.